Connect your AI

Ardelyx ARDX Change in Other Assets

Change in Other Assets at other companies

AmgenAMGN

-$8M-104%

Bausch Health CompaniesBHC

$27M-41.3%

Mineralys Therapeutics, Inc.MLYS

$1.95M-55.7%

Agios PharmaceuticalsAGIO

$2.46M+15.6%

Other financials

Income statement

Revenue$94.5M+27.5%

Gross profit$89.7M+45.1%

Operating income-$32.8M+9.8%

Net income-$37.6M+8.6%

EPS (diluted)-$0.15+11.8%

Balance sheet

Cash & equivalents$31.2M+1.3%

Total debt$208.3M+34.3%

Total equity$148.6M+2.0%

Total assets$504.5M+23.0%

Cash flow

Operating cash flow-$32.2M+16.2%

CapEx$69.0K-78.8%

Free cash flow-$32.3M+16.7%

Valuation

Market cap$1.53B+25.5%

Enterprise value$1.71B+27.1%

P/S3.6×+0.2×

Profitability

Gross margin92.5%+7.9pp

Operating margin-25.4%—

Net margin-13.6%—

FCF margin-40.9%—

Returns & leverage

Return on equity-39.5%—

Debt / equity1.4×+0.3×

Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Ardelyx's change in other assets?: Ardelyx (ARDX) reported change in other assets of $10M in Q1 2026.
How has Ardelyx's change in other assets changed year-over-year?: Ardelyx's change in other assets increased by 99.2% year-over-year, from $5.02M to $10M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.